dm+d

108838001

Articles

Safety in Lactation: Treatment of glaucoma

18 September 2020With the exception of acetazolamide (oral/IV) antiglaucoma drugs are administered as eyedrops which have limited systemic absorption in the mother, and pose negligible risk to…
Search Articles

Lactation Safety Information

Yes
11 September 2020

New Medicines

Glaucoma and ocular hypertension - benzalkonimum chloride (BAK)-free emulsion formulation

Information

New formulation
Santen
Santen

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
None

Category

Prodrug analogue of prostaglandin F2 alfa. The BAK-free cationic emulsion reduces ocular surface damage that is typically caused by eye drops containing BAK. Plus the formulation is stable at room temperature.
Ocular hypertension affects 3-5% of the population over 40 years of age but only a small proportion of these people develop glaucoma. If glaucoma is completely untreated, progression to severe sight impairment typically takes 25-70 years from onset [1].
Glaucoma and ocular hypertension - benzalkonimum chloride (BAK)-free emulsion formulation
Topical